NTLA

Intellia Therapeutics Inc

NASDAQ · Biotechnology

$12.28

+1.19 (+10.73%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Hold

31 analysts

Buy 17 55%

Hold 12 39%

Sell 2 6%

Price Target

Analyst Price Target +164.7% upside

Low Target $20.88

Average Target $32.51

High Target $45.64

Current Price $12.28

Current
$12.28

Target
$32.51

$20.88 $32.51 avg $45.64